Related Experiment Videos

Evidence for activation of microglia in patients with psychiatric illnesses

T A Bayer1, R Buslei, L Havas

  • 1Department of Psychiatry, University of Bonn Medical Center, Germany. bayer@uni-bonn.de

Neuroscience Letters
|September 7, 1999
PubMed

Insights

Microglia activation, indicated by HLA-DR staining, was observed in brains of patients with severe psychiatric illnesses. This suggests microgliosis plays a role in the neuropathology of schizophrenia and affective disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Microglia/macrophages are key responders to central nervous system (CNS) pathology.
  • Human Leukocyte Antigen-DR (HLA-DR) is a marker for activated microglia.

Purpose of the Study:

  • To investigate the role of microgliosis in severe psychiatric illnesses.
  • To examine post-mortem brain tissue from patients with schizophrenia, affective disorder, and Alzheimer's disease.

Main Methods:

  • Immunohistochemical analysis using HLA-DR as a marker.
  • Studied post-mortem frontal cortex and hippocampus samples.
  • Included control specimens and Alzheimer's disease cases for comparison.

Main Results:

  • Abundant microglia immunostaining (HLA-DR positive cells) was found in patients with schizophrenia, affective disorder, and Alzheimer's disease.
  • Microglia activation was present in both gray and white matter across patient groups.
  • Distinct neuropathological changes, including microgliosis, were evident in psychiatric illness brains.

Conclusions:

  • Microgliosis is present in severe psychiatric illnesses like schizophrenia and affective disorder.
  • Activated microglia, as part of the brain's immune response, may be crucial in understanding psychiatric disorder pathophysiology.
  • These findings support distinct neuropathological changes in severe mental illnesses.

Related Concept Videos